chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbnes in toes; Tingling in toes and arm; This case was reported by a consumer via interactive digital media and described the occurrence of numbness in toes in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2022, the patient received the 1st dose of Shingrix. In May 2022, 8 hrs after receiving Shingrix, the patient experienced numbness in toes and tingling of extremity. On an unknown date, the outcome of the numbness in toes was recovered/resolved and the outcome of the tingling of extremity was not recovered/not resolved.   It was unknown if the reporter considered the numbness in toes and tingling of extremity to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-May-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient received 1st dose of Shingrix vaccine one week before date of reporting and 8 hours after developed numbness and tingling in toes. 10 days later, the patient had continued off and on tingling in his/her right arm. The numbness was gone in his/her toes. The patient asked if it was normal.
Patient ended up getting cellulitis from the injetion site, is current being treated with an antibiotic
Information has been received from an office manager concerning a 5 year old boy who was vaccinated with a dose of MMR II and VARIVAX (Merck) in one arm on an unspecified date. Then the patient was vaccinated with a dose of IPOL and diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid in the other arm on the same day. After receiving MMR II and VARIVAX (Merck), the patient's arm was swollen, red and hot from his elbow all the way up to his shoulder. There was no adverse reaction specified on the other arm. The patient was given BENADRYL and CORTIZONE. The reporter believed the patient had recovered since no information was heard from the patient's parents. The patient sought unspecified medical attention. Follow up information was received from an office manager via a letter concerning the patient experienced swelling and redness at the site. Subsequently, the symptoms resolved. The patients name was not available. This is one of several reports received from the same source. Additional information is not expected.
Bruise 15 cm x 5 cm on underside of L arm. States may not have noticed bruise right away, so uncertain about date of onset.
This initial spontaneous case, was received from a pharmacist on 20-Oct-2017, concerns a 11-year-old, child male patient. On 10-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch no: 195216 and expiry date: 30-Apr-2018). On 10-Oct-2017, the patient was administered with influenza vaccine that reached 72F for up to 90 hours and had no adverse effects. It was reported that the FLUCELVAX was left out of the refrigerator for a couple of days. The reporter assessed the case as non-serious. Significant follow-up received up on 26-Oct-2017: It was reported that the patient had no adverse event after the vaccination. Narrative amended accordingly. Significant case correction received 26-Oct-2017: The event 'no adverse event' was removed, expiry date of the product was updated and narrative was amended.
Information has been received from a health professional concerning a 7 year old female who on 04/27/2000 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  Subsequently in February 2004, the patient experienced breakthrough chickenpox.  It was reported that there was a total of 45 cases of breakthrough in the patient's school, including the patient, and 17 were vaccine recipients.  Unspecified medical attention was sought.  There was no product quality complaint involved.  The reporter indicated that the patient's sister and 15 other patients had similar experiences following exposure to varicella virus vaccine live (Oka/Merck).
Narrative: Hospitalization for COVID-19 (8/10-8/18) in fully vaccinated individual (non-agency hospital). Received dexamethasone and monoclonal antibody therapy. Re-admitted 9/4/21 for acute hypoxia (agency hospital). Died on 9/20/21. Principle diagnosis on discharge: acute on chronic hypoxemic respiratory failure, acute exacerbation of COPD, bacterial pneumonia, NSTEMI.
Increasing arm pain, searing quality, radiation of pain down from shoulder to fingers, numbness/tingling in fingers, marked stiffness of shoulder.  Unable to move/lift arm.
The 2nd dose was received on 06-02-21. The next day I had muscle pain and intense cold. Two days later I got a rash on my vaccinated arm. Five days later, my body gradually filled with a rash and itching that appeared first on the chest, then neck and face, then on the back and abdomen and went down to the thighs and finally on the feet and soles of the hands.  Yesterday 02-14-21 I went to the emergency service at Hospital, after being examined, the diagnosis was an allergic reaction to the vaccine I was prescribed a steroid and anti-allergy. Today is the ninth day after receiving the 2nd dose of the vaccine and I still get the rash and itchy
Tingling and mild numbness on dorsal wrist, proximal palm and digits 3-5.; Tingling and mild numbness on dorsal wrist, proximal palm and digits 3-5.; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) lot number: EK9231, via an unspecified route of administration in the left arm, on 06Jan2021 11:00 at a single dose for COVID-19 immunization. Medical history included chronic migraine and allergies to medications, food, or other products including penicillin. Concomitant medication included ethinylestradiol, levonorgestrel (SRONYX) for birth control. The patient previously took piroxicam and experienced allergy. The patient was not pregnant. The patient was not diagnosed with covid-19 prior to vaccination nor was she tested for Covid-19 since vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced tingling and mild numbness on dorsal wrist, proximal palm and digits 3-5 on 07Jan2021, 10:00 AM, with outcome of not recovered. The events were reported as non-serious with no treatment received.
Fever over 100.2 x 3 Wks.  Severe Muscle Pain.  Severe Muscle Stiffness.  Pain and stiffness in shoulders, back, hamstrings.  Impairs movement and function.  Unable to drive or ride in car due to triggering spasms in hamstrings.  Unable to sit for more than a few minutes. Forward flexibility restricted.  Unable to bend over to reach floor or tie shoes.  First week symptoms managed with Tylenol.  Increasing progression of pain and stiffness now requires 800mg or more of Ibuprofen daily and 220mg of naproxin nightly. Symptoms are not improving significantly.  Increasing depression resulting from high level of discomfort and impaired function.
One week after vaccination patient had severe polyarticular arthritis, and generalized weakness, was unable to get out of bed for several days.  Had hand swelling, pain and stiffness lasting several weeks.  All symptoms resolved after a short course of systemic steroids.  Rheumotlogic workup yielded only mild DJD.
Pt recv vax on 10/23/98; 5 min later pt exp shaking chills & myalgia, fever (104)
This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 63-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (had some 40 years before the time of reporting). On 16th October 2018, the patient received the 1st dose of SHINGRIX. On 18th October 2018, 2 days after receiving SHINGRIX, the patient experienced injection site rash, skin warm and skin sensitization. On an unknown date, the outcome of the injection site rash and skin sensitization were unknown and the outcome of the skin warm was recovering/resolving. It was unknown if the reporter considered the injection site rash, skin warm and skin sensitization to be related to SHINGRIX. Additional details were reported as follows. On Tuesday 16th October 2018, the patient received a dose of SHINGRIX on the upper left arm. On Thursday morning 18th October 2018, the patient experienced a rash of sorts starting at the injection site, extending 4 to 6 inches down his left arm and moving towards the front (bicep area). The area was sensitive but not nearly as sensitive to touch. On Thursday evening, the rash area seemed warm to the touch, but at the time of reporting not as warm. The patient was measured temperature of the rash area and it was 93.2 degrees F, while adjacent skin was 88 degrees F. On Thursday the rash was warmer than at the time of reporting. The patient was plan to contact his health care provider on 21st October 2018, but the patient wanted to submit this report and seeking any input from GlaxoSmithKline. The patient was agreed for email and call at any time, if needed.
Excessive bleeding during menstrual period.  Period was on time but it is much heavier than normal, soaking at least one pad per hour for 12hrs. It has not resolved yet as period is not complete but seems to be slowing down.
I was asleep and I woke up because I felt something sticky coming out of my nose. It started like water coming out of a faucet however it was blood. I went to the sink and it continued to pour. The next day I went to the ER. It would stop briefly but I could not breathe from the left side of my nose because it felt like a clot was forming. If I would touch it it would feel like the blood clot was forming again. At the ER is when this blood clot came out like pulling on a rubber band. The day after that I went into a specialist for these kinds of things. He said he could see the vessel and he was going to cauterized it.
rash breakout starting from stomach, back, and down to legs and feet, few on arms.
Mild pain in arm shortly following injection of vaccine. Approximately 9 hours later, rapid onset of flu-like symptoms occured including: full body aches, fatigue, headache, and mild nausea. Advil was taken roughtly every 6 hours while side effects persisted. Late at night the following day 1/20/21, symptoms became more mild and normal activity was resumed. Advil or tylenol was still being taken at this time. All ailments ceased by mid day on 1/21/21.
Few days after first vaccine I noticed a little pimple like irritation on my stomach which grew and spread turned out to be shingles. I took viral medicine for one week. At the time of the second vaccine I was taking the last doze of the viral medicine.  Shingles was almost gone completely.  Very soon I want to say day or two after second vaccine I noticed shingles like appearance on my right arm fold area.  I thought shingles is returning, however it turned out to be a food related eczema flair.
5/11/21 developed chest pain, had initial improvement, then worsening on approx 5/26/21. on 6/4, she was diagnosed with pericarditis and acute CHF,  afib with RVR.  Pericarditis has been treated with indomethacin, colchicine, and she is improving with CRP normalized. Afib treated successfully with cardioversion. she was treated with diuretics for her CHF.
Major cardiac event that required hospitalization. Symptoms included elevated heartbeat up to 200 bpm and afib.  Symptoms lasted approximately 18 hours.
A nurse reported that an employee of a long-term care facility received a dose of flu shield in November 2001. Within 24-48 hrs, the employee developed "flu-like symptoms" that resolved approx 48 hrs after onset. No further info was available at the date of this report.
Fever Blisters on mouth; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Fever Blisters on mouth) and PYREXIA (Fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 07-Mar-2021, the patient experienced PYREXIA (Fever). On 08-Mar-2021, the patient experienced ORAL HERPES (Fever Blisters on mouth). The patient was treated with VALACYCLOVIR [VALACICLOVIR] at an unspecified dose and frequency. At the time of the report, ORAL HERPES (Fever Blisters on mouth) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported.
This spontaneous report was received from 54 year old female patient via Kiosk, reporting on herself and enrolled in market research. The patient's concurrent conditions included high blood pressure, hypertension and diabetes. On 04-NOV-2015, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number and expiration date were not provided). Concomitant medications were not provided. On an unknown date, the patient experienced high blood pressure and had a prolonged hospitalization. At the time of the report, the patient was recovering from high blood pressure. The adverse event of high blood pressure was considered to be not related to ZOSTAVAX by the reporter. Additional information has been requested.
I did travel out of the country prior and I was battling a viral infection on my way home. I woke up this Wednesday feeling awful with a lot of congestion, sore throat, terrible headache, and coughing as well. I had both fevers and achiness all over my body, and so I contacted my PCP and I did request for the monoclonal antibody infusion on the 23rd. After the infusion I have seen significant improvement in symptoms. I am still having headaches and a cough that is improving, I do still have some congestion. I still have some fatigue and body aches.
Patient noticed within a day of shot hurt way more than previous flu shot (hurt very bad). Patient could not even lay on the arm when sleeping and it got worse. 4-5 days later patient went to MD and he said it was not infected and probably having a reaction and would get better but it has not and the patient is going to make another appt. Pt can move arm but horizontal movements are inhibited. Patient said she thought RPh gave shot too high.
Went to the ER several days after shot after experiencing chest pain and difficulty breathing... tests came out fine and started to feel better.  Two weeks later, started experiencing tingling and pins/needles in feet. That sensation slowly shot up my entire body and had trouble walking and coordination was off in a major way. Started having major pain across body. When it felt like it was becoming too much and I needed to go to ER, it slowly started reversing over the course of 4-5 days. Now, I'm 90% recovered.
LEFT ARM WAS SWOLLEN, RED, PAINFUL, FINGER COLD, BODY ACHES. PT WENT TO HOSPITAL AND GOT PRESCRIBED ANTIBIOTICS AND PREDNISONE.
2 hrs after receiving vaccine developed painful, raised (L) lymph node in axilla - no other symptoms.
7/20/2022 I felt allergy symptoms. Worst night was 7/21 for coughing. Started taking guaifenesin on 7/21. 7/23/2022 I tested on an at home COVID 19 test, it was positive. Coughing persists through time of reporting. Did not yet speak to doctor.
The patient has not experienced any symptoms or side effects at this time.; Inbound call from nurse who reports they accidentally administered GARDASIL 9 to a 5 year old patient yesterday 22MAY2023.; This spontaneous report was received from a nurse and refers to a 5-year-old female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On 22-MAY-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, (valid lot number W001494 [expiration date 15-SEP-2024]), administered for prophylaxis (dose, dose number, frequency, vaccination scheme, route of administration and anatomical location were not provided) administered for prophylaxis. The vaccine was intended for the 10-year-old brother of the patient, and they got it mixed up prior to administration (product administered to patient of inappropriate age). The patient has not experienced any symptoms or side effects at this time (no adverse event).
This case was reported by a physician and described the occurrence of shingles in a 76-year-old female patient who received SHINGRIX for prophylaxis. In September 2018, the patient received the 1st dose of SHINGRIX. In October 2018, less than a year after receiving SHINGRIX, the patient experienced shingles. The patient was treated with VALTREX. On an unknown date, the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The patient developed shingles in October 2018. It was relatively mild and she received VALTREX within 72 hours and it resolved completely. The reporter was asking when the patient should receive her 2nd dose of the SHINGRIX vaccine.
Expired vaccine was stored and then administered; Administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) and EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.  No Medical History information was reported. On 07-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered). At the time of the report, PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) and EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. The patient was administered with booster dose. The vial was taken from the freezer on the morning of 07-Apr-2022 and placed in the refrigerator for use on 07-Apr-2022. The vial did not undergo any temperature excursions.
A lot of pain followin vaccination that seemed to clear up after a few days.  About two weeks after her shot, she started with a shooting pain in her shoulder and numness, tingling, and weakness in the left arm and hand.  Being treated for nerve damage in arm with a steroid and therapy. At lease 5 other patients experienced same symptoms after their flu shot given at same clinic (small clinic of about 30 patients).
My upper arm became a painful red welt, cannot even touch it. Very large in size. Hot to the touch. I am 4 days out and still having the same symptoms.
2/20 lt upper arm tender to touch, lump (size of walnut), skin pink, 2/22 LT upper arm red, warm to touch, 2/23 LT upper arm red, warm, slightly edematous, 2/24 LT upper arm sl red, warm, 2/25 LT upper arm edematous, red, warm to touch.
Pain that became more and more localized over time. Pain as movement of arm across and over head. Painful sleeping. Difficulty lifting objects.
Body aches for 24 hours starting the morning after the shot.  10:00pm on April 3, 2021, I had the most severe restless leg I have ever had that seems to start in my tailbone and radiate mainly to my legs and lower back. Sometimes I feel the need to twitch my arms. It's been over a week and the feeling still remains and comes and goes spontaneously for hours at a time.
Within 24 hours post vax, pt developed neck and leg pains. Dx arthralgia.
Triggered reactivation of the dormant virus that causes Shingles. This is the first time I have experienced Shingles.
Received a bad rash on my thighs and my vulva and creases of my legs
Breathing difficulty, low pulse, swollen ankles 7/5/21 7:00AM Admitted to Hospital 7/6/21 5:00PM Multiple treatments on patient Cardiology floor.  Rapid heart rate, fluid retention 7/6/21-7/13/21 Patient died 7/13/21
FATHER LIED ABOUT DAUGHTERS DOB TO GET HER A COVID VACCINE. DOB GIVEN WAS 12/11/2016 MAKING HER JUST ELIGIBLE. UNFORTUNATELY AFTER FURTHER RESEARCH PATIENTS DOB WAS FOUND TO BE 1/11/2019.
Mom states : 7 days after receiving MMR and DTaP. High fever 104-105x 2 days after immunization. Complained of red rash on body. Decreased appetite, swollen lymph nodes.
The day after my second dose I had fatigue, diarrhea and stomach pain. The stomach pain remained for several months. Within these months I was diagnosed with H Pylori. As of today, this condition has cleared up completely. My doctor told me that H Pylori does not get out of control on its own. Something is typically introduced to make it linger.
pt recv vax 15APR96 & 18APR96 pt devel a fever, crying, discomfort, runny nose & cough;pt given APAP for fever;23APR96 pt exp induration & tenderness @ inj site;
Patient developed a fever that peaked at 103.5, and lasted for four days. Waking up hysterical during naps and bedtime, even after the fever has subsided. In addition, patient is very cranky.
Body ache, pain on breasts, puffy eyes, sensitive skin, vaginal irritation, tachycardia, shortness of breath. Patient also reported a resurgence in a stomach hernia.
Only had 0.3ML instead of 0.5ML; Sore arm; Bad headache; Chills; A spontaneous report was received from a 25-years-old female pharmacist (patient) who received Moderna's COVID-19 Vaccine (mRNA-1273) and  experienced only had 0.3ML instead of 0.5ML of vaccine/ incorrect dose administered, headache, chills, and sore arm/ injection site pain.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included spironolactone 50mg.  On 11-Feb-2021, the patient received her second of two planned doses of mRNA-1273 (batch: 030M20A) intramuscularly for prophylaxis of COVID-19 infection.   The patient said she only had 0.3ML instead of 0.5ML. The patient also reported that she had a bad headache and chills the same day after being vaccinated but went well after taking Tyenol. Patient also reported that she had a sore arm. Treatment for the event included paracetamol.   The outcome of event, sore arm, was unknown. The outcome of the events, headache, chills, and only had 0.3ML instead of 0.5ML of vaccine, was considered resolved.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273 (lot # 030M20A)  with associated AEs reported as headache, chills and sore arm
dizziness; weakness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and ASTHENIA (weakness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS (I have allergies.).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (dizziness) and ASTHENIA (weakness). At the time of the report, DIZZINESS (dizziness) and ASTHENIA (weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Pfizer bivalent was given to 5yr old instead of dose 2 of the primary series. No adverse events. No further action indicated.